Avalo Therapeutics, Inc.

NasdaqCM:AVTX Stock Report

Mkt Cap: US$47.1m

Avalo Therapeutics Company Information

Avalo Therapeutics, Inc.'s employee growth, exchange listings and data sources


Key Information

  • Name: Avalo Therapeutics, Inc.
  • Ticker: AVTX
  • Exchange: NasdaqCM
  • Founded: 2011
  • Industry: Biotechnology
  • Sector: Pharmaceuticals & Biotech
  • Implied Market Cap: US$47.071m
  • Shares outstanding: 9.41m
  • Website: https://www.avalotx.com

Number of Employees


Location

  • Avalo Therapeutics, Inc.
  • 540 Gaither Road
  • Suite 400
  • Rockville
  • Maryland
  • 20850
  • United States


Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
AVTXNasdaqCM (Nasdaq Capital Market)YesCommon StockUSUSDNov 2015
C6KDB (Deutsche Boerse AG)YesCommon StockDEEURNov 2015

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2023/01/18 00:00
End of Day Share Price2023/01/17 00:00
Earnings2022/09/30
Annual Earnings2021/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.